Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALIGN TECHNOLOGY INCALGN · Entity 3488 | Director | May 20, 2026 | May 22, 2026 |
| NeuroPace IncNPCE · Entity 5459 | Director | March 20, 2026 | March 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALIGN TECHNOLOGY INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 135,916 |
Reported balance
After 2026-05-20 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-05-20 · Exercise / conversion · Acquired 1,745 · Balance 135,916 F1: The shares are held directly by a trust for the Reporting Person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Exercise / conversion · Disposed 1,745 · Balance 0 F2: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,836 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Grant · Acquired 1,836 · Balance 1,836 F3: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are held directly by a trust for the Reporting Person.
F2: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person.
F3: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date.
NeuroPace Inc
Report date March 20, 2026 · Filed March 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,754 |
Reported balance
After 2026-03-20 transaction · row 1
1 source rowRow 1 · 2026-03-20 · Grant · Acquired 865 · Balance 14,754 F1: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 128,174 |
Reported balance
Holding disclosure · report date 2026-03-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 128,174 F2: Shares are held by Lacob Ventures LLC. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 223,554 |
Reported balance
Holding disclosure · report date 2026-03-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 223,554 F3: Shares are held by LCT18 Investments. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.
F2: Shares are held by Lacob Ventures LLC.
F3: Shares are held by LCT18 Investments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 22, 2026 23:08 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237324 · ownership.xml · derivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,836 Underlying: Common Stock · 1,836 shares Expires not disclosed F3 · derivative.exercise_price: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F3 · derivative.exercise_date: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F3 · derivative.expiration_date: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:08 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237324 · ownership.xml · derivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,745 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. F2 · derivative.exercise_date: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. F2 · derivative.expiration_date: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:08 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237324 · ownership.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 135,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are held directly by a trust for the Reporting Person. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:45 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 865 | $13.00 | $11,245.00 |
DisclosureSEC source: 0001628280-26-020835 · wk-form4_1774385141.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,754 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 21:15 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 678 | $16.59 | $11,248.02 |
DisclosureSEC source: 0001215490-25-000007 · form4-12232025_041223.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,889 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| September 19, 2025 Filed Sep 22, 2025 23:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 1,131 | $9.94 | $11,242.14 |
DisclosureSEC source: 0001215490-25-000004 · form4-09222025_070906.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,211 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 21, 2025 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 1,080 | $10.41 | $11,242.80 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 9 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,080 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 06, 2025 Filed Jun 9, 2025 21:26 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (right to buy) · Derivative | 8,745 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001415889-25-016329 · form4-06092025_050612.xml · derivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,745 Underlying: Common Stock · 8,745 shares Expires 2035-06-05 F1 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,745 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014199 · form4-05222025_090554.xml · derivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,745 Underlying: Common Stock · 1,745 shares Expires not disclosed F2 · derivative.exercise_price: Represents par value of ALGN common stock. F4 · derivative.exercise_date: 100% of the RSUs granted on May 21, 2025 will become vested on the earlier of (i) May 21, 2026 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F4 · derivative.expiration_date: 100% of the RSUs granted on May 21, 2025 will become vested on the earlier of (i) May 21, 2026 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,148 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014199 · form4-05222025_090554.xml · derivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock units ("RSUs") granted on May 22, 2024 vested on May 21, 2025 and shares were delivered to the Reporting Person. F3 · derivative.expiration_date: 100% of the restricted stock units ("RSUs") granted on May 22, 2024 vested on May 21, 2025 and shares were delivered to the Reporting Person. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014199 · form4-05222025_090554.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 134,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are held directly by a trust for the Reporting Person. Read SEC document |
| March 21, 2025 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 935 | $12.02 | $11,238.70 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 8 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,000 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 21, 2024 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 975 | $11.53 | $11,241.75 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 7 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,065 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| September 30, 2024 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 1,614 | $6.97 | $11,249.58 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 6 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,090 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 28, 2024 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 1,488 | $7.56 | $11,249.28 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 5 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,476 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:14 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Rt to Buy) · Derivative | 17,774 | $0.00 Strike: $6.47 | $0.00 |
DisclosureSEC source: 0001415889-24-016352 · form4-06112024_080656.xml · derivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,774 Underlying: Common Stock · 17,774 shares Expires 2034-06-06 F1 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,148 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014473 · form4-05242024_080514.xml · derivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,148 Underlying: Common Stock · 1,148 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock units granted on May 22, 2024 will become vested on the earlier of (i) May 22, 2025 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F2 · derivative.expiration_date: 100% of the restricted stock units granted on May 22, 2024 will become vested on the earlier of (i) May 22, 2025 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:07 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,029 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014025 · form4-05212024_110526.xml · derivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,029 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 17, 2023 became vested on May 17, 2024 and shares were delivered to the Reporting Person. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 17, 2023 became vested on May 17, 2024 and shares were delivered to the Reporting Person. Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:07 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014025 · form4-05212024_110526.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 133,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are held directly by a trust for the reporting person. Read SEC document |
| March 29, 2024 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 852 | $13.20 | $11,246.40 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 4 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,988 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 23:50 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 800 | $304.76 | $243,805.20 |
DisclosureSEC source: 0001415889-24-005990 · form4-02292024_110241.xml · nonDerivative · entry 4 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 131,994 F5 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $304.56 to $304.91, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by a trust for the reporting person is trustee. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 23:50 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 3,676 | $303.59 | $1,115,996.47 |
DisclosureSEC source: 0001415889-24-005990 · form4-02292024_110241.xml · nonDerivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 132,794 F4 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $303.38 to $304.34, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by a trust for the reporting person is trustee. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 23:50 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 10,524 | $302.97 | $3,188,506.80 |
DisclosureSEC source: 0001415889-24-005990 · form4-02292024_110241.xml · nonDerivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 136,470 F3 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $302.36 to $303.29, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by a trust for the reporting person is trustee. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:50 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 10,000 | $313.01 | $3,130,075.00 |
DisclosureSEC source: 0001415889-24-005990 · form4-02292024_110241.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 146,994 F1 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $312.79 to $313.29, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F2 · ownership.nature: The shares are held directly by a trust for the reporting person is trustee. Read SEC document |
| December 29, 2023 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 1,091 | $10.31 | $11,248.21 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,136 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| September 29, 2023 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 1,156 | $9.73 | $11,247.88 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,045 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 30, 2023 Filed Jun 24, 2025 20:30 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 2,505 | $4.49 | $11,247.45 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,889 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 07, 2023 Filed Jun 14, 2023 20:54 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Rt to Buy) · Derivative | 27,380 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001209191-23-037073 · doc4.xml · derivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,380 Underlying: Common Stock · 27,380 shares Expires 2033-06-06 F1 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:23 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,029 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031129 · doc4.xml · derivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,029 Underlying: Common Stock · 1,029 shares Expires not disclosed F2 · derivative.exercise_price: Represents par value of ALGN common stock. F4 · derivative.exercise_date: 100% of the restricted stock unit granted on May 17, 2023 will become vested on the earlier of (i) May 17, 2024 or (i) the date of the 2024 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F4 · derivative.expiration_date: 100% of the restricted stock unit granted on May 17, 2023 will become vested on the earlier of (i) May 17, 2024 or (i) the date of the 2024 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:23 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 1,114 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031129 · doc4.xml · derivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 18, 2022 became vested on May 17, 2023 and shares were delivered to reporting person. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 18, 2022 became vested on May 17, 2023 and shares were delivered to reporting person. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:23 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031129 · doc4.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 156,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are held directly by a trust for which the reporting person is trustee. Read SEC document |
| October 18, 2022 Filed Oct 20, 2022 23:57 UTC | NeuroPace Inc NPCE · Entity 5459 | Exercise / conversionStock Option (Rt to Buy) · Derivative | 192 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001209191-22-054222 · doc4.xml · derivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 192 shares Expires 2022-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The share underlying the option are fully vested. Read SEC document |
| October 18, 2022 Filed Oct 20, 2022 23:57 UTC | NeuroPace Inc NPCE · Entity 5459 | Exercise / conversionCommon Stock | 192 | $0.03 | $4.99 |
DisclosureSEC source: 0001209191-22-054222 · doc4.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2022 Filed Jun 22, 2022 01:10 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 18,253 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001209191-22-038607 · doc4.xml · derivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,253 Underlying: Common Stock · 18,253 shares Expires 2032-06-12 F1 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable. Read SEC document |
| May 18, 2022 Filed May 19, 2022 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,114 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030679 · doc4.xml · derivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114 Underlying: Common Stock · 1,114 shares Expires not disclosed F2 · derivative.exercise_price: Represents par value of ALGN common stock. F4 · derivative.exercise_date: 100% of the restricted stock unit granted on May 18, 2022 will become vested on the earlier of (i) May 18, 2023 or (i) the date of the 2023 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F4 · derivative.expiration_date: 100% of the restricted stock unit granted on May 18, 2022 will become vested on the earlier of (i) May 18, 2023 or (i) the date of the 2023 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 18, 2022 Filed May 19, 2022 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 524 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030679 · doc4.xml · derivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 524 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 19, 2021 became vested on May 18, 2022 and shares were delivered to reporting person. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 19, 2021 became vested on May 18, 2022 and shares were delivered to reporting person. Read SEC document |
| May 18, 2022 Filed May 19, 2022 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 524 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030679 · doc4.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 155,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are held directly by a trust for which the reporting person is the trustee. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:55 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 524 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035045 · doc4.xml · derivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524 Underlying: Common Stock · 524 shares Expires not disclosed F2 · derivative.exercise_price: Represents par value of ALGN common stock. F4 · derivative.exercise_date: 100% of the restricted stock unit granted on May 19, 2021 will become vested on the earlier of (i) May 19, 2022 or (i) the date of the 2022 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F4 · derivative.expiration_date: 100% of the restricted stock unit granted on May 19, 2021 will become vested on the earlier of (i) May 19, 2022 or (i) the date of the 2022 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:55 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 1,271 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035045 · doc4.xml · derivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,271 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 20, 2020 became vested on May 19, 2021 and shares were delivered to reporting person on such vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 20, 2020 became vested on May 19, 2021 and shares were delivered to reporting person on such vest date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:55 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035045 · doc4.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 155,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are held directly by a trust for which the reporting person is the trustee. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:15 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionSeries B' Preferred Stock · Derivative | 205,497 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028322 · doc4.xml · derivative · entry 5 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 20,549 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F4 · ownership.nature: Shares are held by LCT18 Investments. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:15 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionSeries B; Preferred Stock · Derivative | 102,747 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028322 · doc4.xml · derivative · entry 4 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 102,747 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F3 · ownership.nature: Shares are held by Lacob Ventures LLC. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:15 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionSeries A' Preferred Stock · Derivative | 17,189 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028322 · doc4.xml · derivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 17,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F4 · ownership.nature: Shares are held by LCT18 Investments. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:15 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionSeries A' Preferred Stock · Derivative | 8,594 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028322 · doc4.xml · derivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 8,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F3 · ownership.nature: Shares are held by Lacob Ventures LLC. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:15 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 334,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028322 · doc4.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 351,920 F1 · ownership.nature: Includes 111,341 shares held by Lacob Ventures LLC and 222,686 shares held by LCT18 Investments, LLC. Read SEC document |
| April 21, 2021 Filed Oct 8, 2021 22:13 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 21,698 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060103 · doc4.xml · derivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,698 Underlying: Common Stock · 21,698 shares Expires 2031-04-20 F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 23:02 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 5,000 | $300.00 | $1,500,000.00 |
DisclosureSEC source: 0001209191-20-048974 · doc4.xml · nonDerivative · entry 3 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 154,085 F2 · ownership.nature: The shares are held directly by a trust for which the reporting person is the trustee. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 23:02 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 3,085 | $300.32 | $926,477.02 |
DisclosureSEC source: 0001209191-20-048974 · doc4.xml · nonDerivative · entry 2 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 159,085 F3 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.86, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by a trust for which the reporting person is the trustee. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 23:02 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 2,190 | $298.71 | $654,177.75 |
DisclosureSEC source: 0001209191-20-048974 · doc4.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 162,170 F1 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $298.46 to $298.93, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by a trust for which the reporting person is the trustee. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 21:26 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 10,000 | $300.11 | $3,001,116.00 |
DisclosureSEC source: 0001209191-20-048665 · doc4.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 164,360 F1 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.45, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held directly by a trust for which the reporting person is the trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.